Alex Dobbin | Head-Investor Relations |
Rick Winningham | Chief Executive Officer |
Renee Gala | Chief Financial Officer |
Brett Haumann | Chief Medical Officer |
Geoffrey Porges | Leerink Partners |
Josh Schimmer | Evercore |
Peter Stapor | Bank of America |
Neena Bitritto-Garg | Robert W. Baird |
Louise Chen | Cantor Fitzgerald |
Ladies and gentlemen, good afternoon. At this time, I'd like to welcome everyone to the Theravance Biopharma Conference Call. [Operator Instructions] Today's conference call is being recorded. And now I would like to turn the call over to Alex Dobbin, Head of Investor Relations. Please go ahead.